Vaccines A-Z

Precision Vaccinations

 / April 24th, 2024

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Apr 24 • 12:25 pm CDT
Novavax Inc. recently announced its Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) became available to pharmacies across the United Kingdom (U.K.) for private healthcare providers to offer an updated protein-based non-mRNA option as... READ →
Apr 24 • 10:49 am CDT
PharmaJet® today announced that the journal Nature published results from Gennova Biopharmaceutical's Phase 2/3 clinical trial. The trial was conducted to evaluate the safety and immunogenicity of its novel samRNA-based Covid-19 vaccine booster. The study's results... READ →
Apr 24 • 9:54 am CDT
According to data from the Czech State Health Institute (SZU), the number of pertussis cases in 2024 has exceeded 7,888. Local media ( Xinhua ) reported that this outbreak is the most severe in decades. Pertussis... READ →
Apr 24 • 8:22 am CDT
Moderna, Inc. and OpenAI today announced their ongoing collaboration to co-innovate with a shared vision of AI's transformative potential in the future of business and healthcare. Moderna is a digital-first company that has leveraged the power... READ →
Apr 24 • 7:54 am CDT
CureVac N.V. today announced the start of the Phase 1 part of a combined Phase 1/2 clinical trial of an investigational influenza A (H5N1) pre-pandemic vaccine candidate developed in collaboration with GSK. In the initial Phase... READ →

For more articles, try our search.